Abbott Laboratories closed 10.57% short of its 52-week high of $141.23, which the company reached on March 4th.

Today, Benzinga 's options scanner spotted 10 uncommon options trades for Abbott Laboratories. This isn't normal. The overall ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

This was the stock's fourth consecutive day of losses.

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

In contrast to all that, many investors prefer to focus on companies like Abbott Laboratories (NYSE:ABT), which has not only revenues, but also profits. Now this is not to say that the company ...

Health and Human Services Secretary Robert F. Kennedy Jr. plans to meet Tuesday with executives of companies that make infant formula, people ...

Abbott (ABT) in October 2024 won the Whitfield case, though the plaintiffs appealed the Whitfield verdict and on Thursday, the judge granted a ...

Abbott allowed two runs on three hits and one walk while striking out two over three innings in Monday's spring start against the Guardians.

Mead Johnson and Abbott Laboratories are to face a new trial in the US over allegations their premature infant formula can ...